FLUOROQUINOLONE- ASSOCIATED TENDON-RUPTURE: A SUMMARY OF REPORTS IN THE FOOD AND DRUG ADMINISTRATION'S (FDA'S) ADVERSE EVENT REPORTING SYSTEM

被引：1
|
作者：
Arabyat, R. M. [1 ]
Garg, V [2 ]
Raisch, D. W. [3 ]
Bennett, C. [4 ]
机构：
[1] Univ New Mexico, Albuqurque, NM USA
[2] Univ New Mexico, Albuquerque, NM 87131 USA
[3] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
[4] Univ S Carolina, Columbia, SC 29208 USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1101
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A217 / A217
页数：1
相关论文
共 50 条
  • [1] Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system
    Arabyat, Rasha M.
    Raisch, Dennis W.
    McKoy, June M.
    Bennett, Charles L.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (11) : 1653 - 1660
  • [2] HMG-COA REDUCTASE INHIBITORS (STATINS) ASSOCIATED TENDON RUPTURE: AN ANALYSIS OF REPORTS FROM THE FOOD AND DRUG ADMINISTRATION'S ADVERSE REPORTING SYSTEM
    Rafi, J. A.
    Arabyat, R.
    Chen, C.
    Raisch, D. W.
    VALUE IN HEALTH, 2016, 19 (03) : A39 - A39
  • [3] Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration’s Adverse Event Reporting System
    James R. Rogers
    Ameet Sarpatwari
    Rishi J. Desai
    Justin M. Bohn
    Nazleen F. Khan
    Aaron S. Kesselheim
    Michael A. Fischer
    Joshua J. Gagne
    John G. Connolly
    Drug Safety, 2019, 42 : 85 - 93
  • [4] Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting System
    Rogers, James R.
    Sarpatwari, Ameet
    Desai, Rishi J.
    Bohn, Justin M.
    Khan, Nazleen F.
    Kesselheim, Aaron S.
    Fischer, Michael A.
    Gagne, Joshua J.
    Connolly, John G.
    DRUG SAFETY, 2019, 42 (01) : 85 - 93
  • [5] A Summary of the Rare Reports of Osteonecrosis of the Jaw Associated With Tumor Necrosis-a Inhibitors in the United States Food and Drug Administration's Adverse Event Reporting System Database
    Wichelmann, Thomas Adam
    Ahdi, Hardeep S.
    Pandravada, Sasirekha
    Ehrenpreis, Eli D.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2023, 81 (10) : 1311 - 1318
  • [6] Pediatric drug surveillance and the food and drug administration's adverse event reporting system: an overview of reports, 2003-2007
    Johann-Liang, Rosemary
    Wyeth, Jo
    Chen, Min
    Cope, Judith U.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (01) : 24 - 27
  • [7] PROGRESIVE MULTIFOCAL LEUKOENCEPHALOPATHY WITH NEW BIOLOGICALS AND TARGETED CANCER THERAPIES: SUMMARY OF REPORTS TO THE FOOD AND DRUG ADMINISTRATION'S ADVERSE EVENT REPORTING SYSTEM (FAERS)
    Raisch, D. W.
    Bennett, C. L.
    Rafi, J. A.
    Chen, C.
    VALUE IN HEALTH, 2016, 19 (03) : A133 - A133
  • [8] Priapism associated with antiepileptic drugs: a disproportionality analysis in the food and drug administration's adverse event reporting system
    Pejcic, A.
    Milosavljevic, M.
    Milosavljevic, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S438 - S438
  • [9] Dalfampridine Associated Serious Adverse Events: An Analysis of Data from the Food and Drug Administration's Adverse Event Reporting System
    Ahmed, Nehad J.
    Alahmari, Abdullah K.
    Alshehri, Ahmed M.
    Almalki, Ziyad S.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (06): : 1195 - 1199
  • [10] Performance of subgrouped proportional reporting ratios in the US food and drug administration (FDA) adverse event reporting system
    Dauner, Dan
    Zhang, Rui
    Adam, Terrence
    Leal, Eleazar
    Farley, Joel F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 598 - 598
12345